Table 1.

Changes in size and cellularity of spleens and numbers of splenic erythroblasts of naive or P chabaudi AS-infected mice after EPO treatment




N*

N + EPO

I*

I + EPO
Spleen index, %   0.29 ± 0.01a  0.87 ± 0.01b  1.34 ± 0.08c  1.43 ± 0.07c 
Cellularity, × 106 cells   25.00 ± 2.52a  160.50 ± 5.74b  180.40 ± 27.26b  178.00 ± 19.34b 
TER119+, × 106 cells   0.51 ± 0.08a  36.33 ± 2.05b  14.53 ± 2.62c  10.87 ± 0.93c 
Hb-positive, × 106 cells   0.17 ± 0.01a  27.24 ± 0.62b  4.17 ± 1.02c  3.97 ± 0.15c 
Hb-positive/TER119+
 
34.67 ± 6.41a
 
74.99 ± 4.81b
 
29.21 ± 3.84a
 
30.18 ± 2.91a
 



N*

N + EPO

I*

I + EPO
Spleen index, %   0.29 ± 0.01a  0.87 ± 0.01b  1.34 ± 0.08c  1.43 ± 0.07c 
Cellularity, × 106 cells   25.00 ± 2.52a  160.50 ± 5.74b  180.40 ± 27.26b  178.00 ± 19.34b 
TER119+, × 106 cells   0.51 ± 0.08a  36.33 ± 2.05b  14.53 ± 2.62c  10.87 ± 0.93c 
Hb-positive, × 106 cells   0.17 ± 0.01a  27.24 ± 0.62b  4.17 ± 1.02c  3.97 ± 0.15c 
Hb-positive/TER119+
 
34.67 ± 6.41a
 
74.99 ± 4.81b
 
29.21 ± 3.84a
 
30.18 ± 2.91a
 

Data are means ± SEM for 4 to 5 mice per group. ANOVA in conjunction with Tukey post-hoc analysis was employed to analyze statistical differences among data from N, N+EPO, I, and I+EPO. Results of statistical comparison are indicated by lowercase letter superscripts assigned to each set of data. When 2 sets of data are labeled with superscripts of different lowercase letters, it indicates that the 2 sets of data are statistically different (P < .05). Similar results were obtained in 3 independent experiments.

EPO indicates erythropoietin; N, naive mice; N + EPO, naive mice treated with EPO; I, infected mice; I + EPO, infected mice treated with EPO; Hb, hemoglobin.

*

Spleens from naive and P chabaudi AS-infected A/J mice without treatment or treated with 0.1% BSA solution were used as controls. No significant differences between spleens from untreated mice or 0.1% BSA-treated mice were observed. Therefore, only data from untreated mice are reported here.

Naive or infected A/J mice were treated with 10 units of rmEPO per day for 3 consecutive days. Mice were humanely killed 1 day following the completion of the treatment, and spleen parameters were assessed.

Data were calculated by dividing the number of Hb-positive cells by the number of TER119+ cells and multiplying by 100%.

Close Modal

or Create an Account

Close Modal
Close Modal